These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2704233)

  • 21. Cultured thyroid allografts induce a state of partial tolerance in adult recipient mice.
    Donohoe JA; Andrus L; Bowen KM; Simeonovic C; Prowse SJ; Lafferty KJ
    Transplantation; 1983 Jan; 35(1):62-7. PubMed ID: 6823693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Tolerance and Skin Allograft Survival in CD200tg Mice After Autologous Marrow Transplantation.
    Gorczynski R; Chen Z; Khatri I; Yu K
    Transplantation; 2014 Dec; 98(12):1271-8. PubMed ID: 25340612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of gene expression profile in CD200 transgenic skin allografts is associated with graft survival on retransplantation to normal recipients.
    Yu K; Gorczynski RM
    Transplantation; 2012 Jul; 94(1):36-42. PubMed ID: 22683854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reepithelialized orthotopic tracheal allografts expand memory cytotoxic T lymphocytes but show no evidence of chronic rejection.
    Cleven HA; Genden EM; Moran TM
    Transplantation; 2005 Apr; 79(8):861-8. PubMed ID: 15849536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New method for thyroid transplantation across major histocompatibility complex barriers using allogeneic bone marrow transplantation.
    Lee S; Sugiura K; Nagahama T; Iwai H; Yasumizu R; Yamashita T; Ikehara S
    Transplantation; 2001 Sep; 72(6):1144-9. PubMed ID: 11579314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.
    Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C
    Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.
    Yazawa N; Imaizumi T; Makuuchi H; Tsuchiya I; Tanaka M; Inokuchi S; Habu S; Nakagohri T
    Tokai J Exp Clin Med; 2015 Dec; 40(4):141-8. PubMed ID: 26662664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of IL-4 deletion on cardiac allograft survival in the BALB/c to 129Sv x C57BL/6 strain combination.
    Mottram P; Murray-Segal LJ; Li YQ; Han WR; Sandrin M; McKenzie IF
    Immunol Cell Biol; 1998 Dec; 76(6):563-5. PubMed ID: 9893036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third-party grafts bearing new antigens when associated with tolerogenic antigens.
    La Rosa FG; Smilek D; Talmage DW; Lafferty KJ; Bauling P; Ammons TJ
    Transplantation; 1992 Apr; 53(4):903-13. PubMed ID: 1566357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.
    Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G
    J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid graft rejection between C57BL/6 and H-2Kb mutant mice. Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants.
    Isakov N; Bach FH
    Transplantation; 1983 Nov; 36(5):571-7. PubMed ID: 6356521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid allograft immunogenicity is reduced after a period in organ culture.
    Lafferty KJ; Cooley MA; Woolnough J; Walker KZ
    Science; 1975 Apr; 188(4185):259-61. PubMed ID: 1118726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state.
    Coulombe M; Gill RG
    Transplantation; 1994 Apr; 57(8):1195-200. PubMed ID: 8178346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to cultured allografts protects third-party grafts containing new MHC and common minor antigens.
    La Rosa FG; Talmage DW
    Transplantation; 1987 Feb; 43(2):314-6. PubMed ID: 3580040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.